New treatment for children with HIV shows promise
Roger Shapiro, professor of immunology and infectious diseases, discusses his recent study of a new treatment option for children living with HIV.
Decade-long research project that explores aging in South Africa receives NIH/NIA funding for additional waves and national expansion, with a special emphasis on cognitive health
Researchers from the Harvard Center for Population and Development Studies, Harvard Chan School, the University of the Witwatersrand, and the University of Cape Town have been awarded $27 million from the National Institute on Aging to further their…
Strength in numbers
Octavious Smiley, PhD ’23, is dedicated to helping the next generation of minority students excel in the field of biostatistics.
Complexities of homelessness explored at ‘deep dive’ event
Many facets related to the problem of homelessness—including its prevalence, causes, relationship to health, and ways to respond—were on the agenda at a two-day conference at Harvard University in late March.
Genital herpes linked with economic, quality of life losses in low- and middle-income countries
Genital herpes is driving significant losses to both economies and quality of life in low- and middle-income countries, according to a new study co-authored by researchers from Harvard Chan School.
The complicated work of pinpointing the causes of disease
Three epidemiologists discussed the challenge of uncovering the causes of diseases at the 6th Cutter Symposium at Harvard Chan School.
Both rich and poor countries saw essential health services decline during COVID
Many essential health services—including cancer and tuberculosis screenings, HIV testing, maternal health services, and child vaccinations—declined during the COVID-19 pandemic in poor and rich countries alike around the globe, according to a new study co-authored by Harvard Chan…
Tracking emotional and behavioral issues in youth born to women with HIV
Among youth born to women with HIV, those who were born without HIV had worse behavioral functioning than those born with HIV, a new study found.
Getting to know … Austin Marshall, MPH ’21
Austin Marshall, MPH '21, wants to be a physician-advocate for the LGBTQ+ community. He also sings Indian classical music, competes in esports, and fixes iPhones.
Evaluating the safety of TDF, an HIV drug, for pregnant women facing COVID-19
Among pregnant women who use the HIV drug tenofovir disoproxil fumarate, there was no greater risk of malformations in their newborns than from other antiretroviral therapies, according to new research from Harvard Chan School.